Malignant solid tumor cell

Malignant solid tumor cells are abnormal cells characterized by uncontrolled proliferation, resistance to programmed cell death, and the ability to invade surrounding tissues and metastasize to distant organs. Unlike hematological malignancies, these cells form distinct anatomical masses in various organs such as the lungs, breast, or colon. They are defined by a complex landscape of genetic mutations and epigenetic alterations that dysregulate homeostatic biological processes, including the cell cycle and metabolic signaling (NIH National Cancer Institute, 2023). \n\nIn the context of drug discovery, 'Malignant solid tumor cells' refers to the disease state or indication rather than a specific therapeutic target molecule like a receptor or enzyme. While drugs like chemotherapy and targeted therapies aim to eliminate these cells, they do so by interacting with specific intracellular or surface molecules (e.g., EGFR, HER2, or DNA). The study of these cells involves understanding the tumor microenvironment and the various mechanisms cancer cells use to evade the host immune system (Hanahan & Weinberg, 2011; PubMed ID: 21376230).

Other names

Cancer cellSolid tumor cellMalignant neoplasm cellTumor cell

Malignant solid tumor cells are not a single molecular target but a pathological cell population. Therapeutic strategies against these cells involve disrupting DNA replication (alkylating agents), inhibiting mitosis (taxanes), blocking growth factor receptors (targeted antibodies/TKIs), or enhancing immune recognition (checkpoint inhibitors) to induce cell death or growth arrest (Hanahan & Weinberg, 2011).